Loading...
Pirin: a potential novel therapeutic target for castration‐resistant prostate cancer regulated by miR‐455‐5p
Androgen deprivation therapy is frequently used to treat prostate cancer (PCa), but resistance can occur, a condition known as castration‐resistant prostate cancer (CRPC). Thus, novel approaches for identification of CRPC are important for designing effective PCa treatments. Analysis of microRNA (mi...
Na minha lista:
| Udgivet i: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6360383/ https://ncbi.nlm.nih.gov/pubmed/30444038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12405 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|